Dose-response meta-analysis on urate, gout, and the risk for Parkinson’s disease
Abstract The relationship between Parkinson’s disease (PD) and urate or gout has attracted significant interest in recent years, but the results were conflicting. This dose-response meta-analysis aimed to estimate the correlation between urate levels or gout and the risk for PD. The Embase, PubMed,...
Main Authors: | Hongtao Chang, Benqiao Wang, Yue Shi, Ruixia Zhu |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2022-11-01
|
Series: | npj Parkinson's Disease |
Online Access: | https://doi.org/10.1038/s41531-022-00433-5 |
Similar Items
-
The relationship between ferritin and urate levels and risk of gout
by: Tahzeeb Fatima, et al.
Published: (2018-08-01) -
Systemic Urate Deposition: An Unrecognized Complication of Gout?
by: Puja Khanna, et al.
Published: (2020-10-01) -
Prescription and dosing of urate-lowering therapy, rather than patient behaviours, are the key modifiable factors associated with targeting serum urate in gout
by: Dalbeth Nicola, et al.
Published: (2012-09-01) -
The Effect of Decrease in Serum Urate for the Risk of Gout Flares During Urate-Lowering Therapy Initiation Among Chinese Male Gout Patients: A Prospective Cohort Study
by: Pang L, et al.
Published: (2023-09-01) -
Uric acid, gout and cardiovascular diseases: prospects for the use of urat-lowering medications
by: M. S. Eliseev, et al.
Published: (2019-08-01)